CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-09 | Davis George Eric EVP, Chief Legal Officer | Sale | −3,690 | $96.34 | $355K | 55,251 |
| 2022-08-09 | Davis George Eric EVP, Chief Legal Officer | Exercise or conversion | +47,526 | $67.81 | $3.2M | 102,777 |
| 2022-08-09 | Davis George Eric EVP, Chief Legal Officer | Sale | −47,526 | $95.93 | $4.6M | 55,251 |
| 2022-08-09 | Davis George Eric EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −47,526 | 0 | ||
| 2022-08-08 | Guyer Charles Greg EVP, Chief Technical Officer | Sale | −6,205 | $96.56 | $599K | 42,168 |
| 2022-08-05 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion | +3,500 | $67.81 | $237K | 34,226 |
| 2022-08-05 | Mueller Brian EVP, Chief Financial Officer | Sale | −3,500 | $94.50 | $331K | 30,726 |
| 2022-08-05 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −3,500 | 7,261 | ||
| 2022-07-08 | Mueller Brian EVP, Chief Financial Officer | Sale | −7,337 | $89.50 | $657K | 30,726 |
| 2022-07-08 | Davis George Eric EVP, Chief Legal Officer | Sale | −7,398 | $90.00 | $666K | 58,941 |
| 2022-06-29 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −576 | $83.92 | $48K | 38,063 |
| 2022-06-03 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Shares withheld for taxes | −7,021 | $77.49 | $544K | 47,088 |
| 2022-05-26 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Sale | −1,308 | $78.94 | $103K | 54,109 |
| 2022-05-24 | Slamon Dennis Director | Grant or award | +4,980 | 26,619 | ||
| 2022-05-24 | PYOTT DAVID E I Director | Grant or award | +4,980 | 40,840 | ||
| 2022-05-24 | MEIER RICHARD A Director | Grant or award | +4,980 | 108,994 | ||
| 2022-05-24 | LAWLIS V BRYAN Director | Grant or award | +4,980 | 28,950 | ||
| 2022-05-24 | HOMBACH ROBERT J. Director | Grant or award | +4,980 | 26,310 | ||
| 2022-05-24 | Ho Maykin Director | Grant or award | +4,980 | 12,450 | ||
| 2022-05-24 | HERON ELAINE J Director | Grant or award | +4,980 | 85,568 |
Page 21 of 23 · 450 trades